CARDLYTICS, INC. (CDLX) Revenue 2016–2025
CARDLYTICS, INC. (CDLX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$212.3MFY2025 · since FY2016: $112.8M → $212.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $212.3M | -16.9% |
| FY2024 | $255.6M | -10.4% |
| FY2023 | $285.4M | +3.0% |
| FY2022 | $277.2M | +7.1% |
| FY2021 | $258.8M | +38.5% |
| FY2020 | $186.9M | -11.2% |
| FY2019 | $210.4M | +39.6% |
| FY2018 | $150.7M | +15.6% |
| FY2017 | $130.4M | +15.6% |
| FY2016 | $112.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Operating cash flowCDLX Free cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →